1. Home
  2. ERII vs ARDX Comparison

ERII vs ARDX Comparison

Compare ERII & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERII
  • ARDX
  • Stock Information
  • Founded
  • ERII 1992
  • ARDX 2007
  • Country
  • ERII United States
  • ARDX United States
  • Employees
  • ERII N/A
  • ARDX N/A
  • Industry
  • ERII Industrial Machinery/Components
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ERII Technology
  • ARDX Health Care
  • Exchange
  • ERII Nasdaq
  • ARDX Nasdaq
  • Market Cap
  • ERII 762.9M
  • ARDX 882.9M
  • IPO Year
  • ERII 2008
  • ARDX 2014
  • Fundamental
  • Price
  • ERII $14.42
  • ARDX $6.52
  • Analyst Decision
  • ERII Buy
  • ARDX Strong Buy
  • Analyst Count
  • ERII 3
  • ARDX 9
  • Target Price
  • ERII $18.67
  • ARDX $10.50
  • AVG Volume (30 Days)
  • ERII 391.3K
  • ARDX 3.5M
  • Earning Date
  • ERII 10-29-2025
  • ARDX 10-30-2025
  • Dividend Yield
  • ERII N/A
  • ARDX N/A
  • EPS Growth
  • ERII 25.10
  • ARDX N/A
  • EPS
  • ERII 0.43
  • ARDX N/A
  • Revenue
  • ERII $141,775,000.00
  • ARDX $386,146,000.00
  • Revenue This Year
  • ERII $6.16
  • ARDX $16.83
  • Revenue Next Year
  • ERII $13.06
  • ARDX $28.55
  • P/E Ratio
  • ERII $33.43
  • ARDX N/A
  • Revenue Growth
  • ERII 6.19
  • ARDX 83.88
  • 52 Week Low
  • ERII $10.86
  • ARDX $3.21
  • 52 Week High
  • ERII $20.27
  • ARDX $7.18
  • Technical
  • Relative Strength Index (RSI)
  • ERII 55.02
  • ARDX 79.80
  • Support Level
  • ERII $13.92
  • ARDX $6.38
  • Resistance Level
  • ERII $14.47
  • ARDX $6.65
  • Average True Range (ATR)
  • ERII 0.34
  • ARDX 0.22
  • MACD
  • ERII -0.05
  • ARDX 0.00
  • Stochastic Oscillator
  • ERII 55.56
  • ARDX 85.53

About ERII Energy Recovery Inc.

Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: